Rosalind Kalb from the National Multiple Sclerosis Society: Treating Advanced Disease in Multiple Sclerosis

Video

Defining what advanced disease means in multiple sclerosis is a topic open for discussion. Deciding a course of treatment after that determination is another challenge in overall patient care.

Defining what advanced disease means in multiple sclerosis is a topic open for discussion. Deciding a course of treatment after that determination is another challenge in overall patient care.

Rosalind Kalb, PhD, from the National Multiple Sclerosis Society discussed this issue during the annual meeeting of the Consortium of Multiple Sclerosis Centers in National Harbor, Maryland. Kalb said that while there may be disagreement on what qualifies as advanced disease there is no question that patients in this classification need a specialized level of care through the later stages of their disease.

Related Videos
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Veraprapas Kittipibul, MD | Credit: X.com
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.